Characteristic | MDD (n = 25) | Schizophrenia (n = 17) | Total Patients (N = 42) |
---|---|---|---|
Sex, n (%) | |||
Male | 9 (36) | 11 (65) | 20 (48) |
Female | 16 (64) | 6 (35) | 22 (52) |
Age, years | |||
Mean (range) | 46.4 (23–70) | 45.5 (25–59) | 46.0 (23–70) |
Race/ethnicity,a n (%) | |||
White | 20 (80) | 9 (53) | 29 (69) |
African American | 3 (12) | 8 (47) | 11 (26) |
Asian | 1 (4) | 0 (0) | 1 (2) |
Hispanic/Latino | 1 (4) | 1 (6) | 2 (5) |
Mixed race | 0 (0) | 1 (6) | 1 (2) |
Current atypical medications, n (%)b | |||
Quetiapine | 6 (24) | 2 (12) | 8 (19) |
Aripiprazole | 6 (24) | 2 (12) | 8 (19) |
Risperidone | 3 (12) | 4 (24) | 7 (17) |
Olanzapine | 0 (0) | 4 (24) | 4 (10) |
Lurasidone | 3 (12) | 2 (12) | 5 (12) |
Clozapine | 1 (4) | 2 (12) | 3 (7) |
Ziprasidone | 2 (8) | 1 (6) | 3 (7) |
Paliperidone | 0 (0) | 1 (6) | 1 (2) |
Fluphenazine | 0 (0) | 1 (6) | 1 (2) |
Asenapine | 0 (0) | 1 (6) | 1 (2) |